|
First findings released from Swaziland HIV incidence measurement survey announced at CROI 2012
8-Mar-2012 - Seattle, Washington - The first findings from a nationally representative HIV survey were
presented today at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) in Seattle, WA. The Swaziland HIV
Incidence Measurement Survey (SHIMS) found that overall HIV prevalence, or percentage of the population living with HIV
infection, is 31% among adults ages 18-49. This figure matches the 2006 Demographic Health Survey findings for the
same age group, indicating that the HIV epidemic in Swaziland has stabilized over the past five years.
"The country continues to have the highest national HIV prevalence rate in the world, making this the most serious
health issue in Swaziland. The Ministry of Health is using the findings from the SHIMS to tailor and improve HIV prevention, care,
and treatment programs in Swaziland," said Rejoice Nkambule, Deputy Director of Health Services - Public Health at the
Ministry of Health.
The SHIMS was led by the Swaziland Ministry of Health and supported by the U.S. Centers for Disease Control and
Prevention (CDC) and ICAP at Columbia University's Mailman School of Public Health through the U.S. Presidents Plan for AIDS
Relief (PEPFAR). This research is a multi-phase study designed to evaluate the effectiveness of HIV prevention services in
the country. The first phase of the SHIMS survey, now complete, included approximately 13,000 households in Swaziland,
representing a cross-section of the national population and consisting of 18,105 men and women, ages 18-49.
Findings from this first phase indicate that the national prevalence of HIV is 31% among adults ages 18-49. Current
prevalence peaks at 54% for women ages 30-34 and at 48% for men ages 35-39, which is higher than past estimates. The increase in
prevalence among this group of adults in their thirties may be due to an increased number of people living longer with HIV as
a result of expanded access to life-saving antiretroviral therapy (ART). At the same time, HIV prevalence has declined among
women less than 30 years old and men less than 35 years old. Trends from the Swaziland Antenatal HIV Sentinel Surveillance
Surveys also indicate declines in HIV prevalence among young women. This shift might mean that the rate of new HIV
infections among young adults has declined.
The majority of women (68%) who tested HIV-positive during the SHIMS survey were already aware of their status. However,
half (48%) of the men who tested HIV-positive in SHIMS were not aware of their status. As such, improving strategies to engage more
men in HIV testing and encourage their use of healthcare services is necessary.
Furthermore, half (50%) of all HIV-positive adults who were aware of their HIV infection prior to SHIMS reported current
use of ART. It is important to note that these results do not reflect the proportion who are eligible for ART by CD4 count (an
indicator of the stage of HIV infection). Rapid scale-up and decentralization of HIV services since 2005 have resulted in an
increased number of people on ART in Swaziland. Since ART treatment is now understood to prevent the spread of new
infections, the scale-up of ART may also have contributed to lower prevalence rates among younger adults.
"This study may give us the opportunity to look at a 'before-and-after' picture of HIV infection rates in Swaziland.
It is remarkable that in just one year, thousands of individuals have received HIV testing, learned of their HIV status, and were
referred for care, treatment, and prevention services through SHIMS," said Ms. Nkambule.
Along with Ms. Nkambule, the principal investigators on SHIMS include Dr. George Bicego, CDC country director in
Swaziland; Dr. Jessica Justman, ICAP senior technical director; and Dr. Jason Reed, CDC Atlanta, medical epidemiologist in the
Center for Global Health, Division of Global HIV/AIDS. Additional support for SHIMS has been provided by Swaziland's National
Reference Laboratory and Central Statistical Office, Statistical Center for HIV/AIDS Research & Prevention (SCHARP) at
the Fred Hutchinson Cancer Center in the United States, and Maromi Health Research and EpiCentre in South Africa.
###
About the Swaziland Ministry of Health
The Ministry of Health seeks to improve the health status of the people of Swaziland by providing preventive, promotive,
curative and rehabilitative services that are of high quality, relevant, accessible, affordable, equitable and socially acceptable.
About PEPFAR and CDC
The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) was launched in 2003 to combat global HIV/AIDS, and represents
the largest commitment in history by any nation to combat a single disease. Working in partnership with host nations, PEPFAR has directly
supported life-saving antiretroviral treatment (ART) for nearly 4 million people and will support an additional 2 million people on ART
by 2013. As the science-based public health and disease prevention agency in the United States, the Centers for Disease Control and
Prevention (CDC) plays an essential role in implementing PEPFAR by providing support to over 75 countries to strengthen their
national HIV/AIDS programs and build sustainable public health systems. For more information, please
visit http://www.PEPFAR.gov and http://www.cdc.gov/globalaids .
About ICAP
ICAP at Columbia University's Mailman School of Public Health is a global leader in public health, with a broad portfolio
of research, training, health system strengthening, and service delivery programs in the United States and around the world. Founded
in 2004, ICAP is committed to addressing critical health issues and to bettering lives by improving access to high-quality,
equitable, and affordable health services. Working hand-in-hand with in-country partners, ICAP has supported more than
1,200 health facilities across 21 countries. More than one million people have received HIV services through
ICAP-supported programs. For more information about ICAP, visit http://www.columbia-icap.org .
Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health
Source: Eurekalert !
http://www.eurekalert.org/pub_releases/2012-03/cums-ffr030812.php
|
